Literature DB >> 19683026

The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism.

Tina B Lonsdorf1, Christian Rück, Jan Bergström, Gerhard Andersson, Arne Ohman, Martin Schalling, Nils Lindefors.   

Abstract

The short allele of a functional polymorphism (5-HTTLPR) in the serotonin transporter (5-HTT) promoter is associated with reduced serotonin transporter expression, lower in vivo 5-HTT binding, higher neuroticism and amygdala reactivity as well as facilitated fear conditioning and is a candidate variant for panic disorder. However, case-control studies have consistently failed to show an association between 5-HTTLPR and panic disorder. As psychiatric disorders are broadly defined phenotypes merging different symptoms to syndromes, they may not be very well suited for genetic association studies. An alternative approach is to measure symptoms along continuous symptom dimensions which may more appropriately reflect their biological underpinnings and may reveal subpopulations within clinical diagnostic groups. We recorded the symptomatic profile in 73 in panic disorder patients using observer-rated instruments (Panic Disorder Severity Scale, PDSS; Montgomery-Asberg Depression Rating Scale, MADRS) and hypothesized more severe symptoms in patients carrying the 5-HTTLPR s-allele. We observed a strong association between bi- and triallelic 5-HTTLPR polymorphisms and the symptomatic profile. Carriers of the 5-HTTLPR s-allele suffered from most severe panic and depressive symptoms. Our data highlight the importance of defining appropriate phenotypes for psychiatric genetic studies and demonstrate that the 5-HTTLPR genotype may be related to the symptomatic profiles rather than to the vulnerability to develop panic disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683026     DOI: 10.1016/j.pnpbp.2009.08.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  16 in total

Review 1.  Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

Authors:  Philip L Johnson; Lauren M Federici; Anantha Shekhar
Journal:  Neurosci Biobehav Rev       Date:  2014-08-15       Impact factor: 8.989

2.  Associations between serotonin transporter and behavioral traits and diagnoses related to anxiety.

Authors:  Ardesheer Talati; Zagaa Odgerel; Priya J Wickramaratne; Andrea Norcini-Pala; Jamie L Skipper; Jay A Gingrich; Myrna M Weissman
Journal:  Psychiatry Res       Date:  2017-03-21       Impact factor: 3.222

3.  Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.

Authors:  Min-Hyeon Park; Erica Sanders; Meghan Howe; Manpreet Singh; Joachim Hallmayer; Eunjoo Kim; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-28       Impact factor: 2.576

4.  BDNFval66met affects neural activation pattern during fear conditioning and 24 h delayed fear recall.

Authors:  Tina B Lonsdorf; Armita Golkar; Kara M Lindström; Jan Haaker; Arne Öhman; Martin Schalling; Martin Ingvar
Journal:  Soc Cogn Affect Neurosci       Date:  2014-08-07       Impact factor: 3.436

5.  Anxiety disorders in headache patients in a specialised clinic: prevalence and symptoms in comparison to patients in a general neurological clinic.

Authors:  D Mehlsteibl; C Schankin; P Hering; P Sostak; A Straube
Journal:  J Headache Pain       Date:  2011-02-06       Impact factor: 7.277

Review 6.  The genetic basis of panic disorder.

Authors:  Hae-Ran Na; Eun-Ho Kang; Jae-Hon Lee; Bum-Hee Yu
Journal:  J Korean Med Sci       Date:  2011-05-18       Impact factor: 2.153

7.  The 5-HTTLPR confers susceptibility to anorexia nervosa in Han Chinese: evidence from a case-control and family-based study.

Authors:  Jue Chen; Qing Kang; Wenhui Jiang; Juan Fan; Mingdao Zhang; Shunying Yu; Chen Zhang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter.

Authors:  Ivo Heitland; Lucianne Groenink; Elisabeth Y Bijlsma; Ronald S Oosting; Johanna M P Baas
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

Review 9.  A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment.

Authors:  T B Lonsdorf; R Kalisch
Journal:  Transl Psychiatry       Date:  2011-09-20       Impact factor: 6.222

10.  Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder.

Authors:  Evelyn Andersson; Christian Rück; Catharina Lavebratt; Erik Hedman; Martin Schalling; Nils Lindefors; Elias Eriksson; Per Carlbring; Gerhard Andersson; Tomas Furmark
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.